Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GlucoTab with insulin glargine U300 in non-critically ill inpatients with type 2 diabetes
DRKS00011487Phase 4Completed
- Sponsor
- Universitätsklinik für Innere Medizin
- Start
- Jan 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of insulin glargine and human insulin in type 2 diabetes mellitus (T2DM), sponsored by Universitätsklinik für Innere Medizin. Started Jan 2017; status: completed.
02
Drugs
insulin glarginehuman insulin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on DRKS00011487.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00011487.